check_circleStudy Completed
Therapeutic Equivalency, Biological Availability, Postmenopause
Bayer Identifier:
91340
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to investigate the bioequivalence and bioavailability of different formulations containing 0.030 mg Ethinylestradiol and 0.125 mg Levonorgestrel in postmenopausal women
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
39Trial Dates
May 2004 - September 2004Phase
Phase 1Could I Receive a placebo
N/AProducts
Minisiston/Monostep (EE30/LNG, BAY86-4977)Accepts Healthy Volunteer
N/APrimary Outcome
Secondary Outcome
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A